Yang W, Gu M, Zhang Y, Zhang Y, Liu T, Wu D
Sci Rep. 2025; 15(1):5812.
PMID: 39962075
PMC: 11832748.
DOI: 10.1038/s41598-025-85620-z.
Yang L, Li S, Yu L, Leng J, Li N
Front Immunol. 2025; 15:1522392.
PMID: 39877360
PMC: 11772265.
DOI: 10.3389/fimmu.2024.1522392.
Lypova N, Dougherty S, Clem B, Feng J, Yin X, Zhang X
Cancer Metab. 2024; 12(1):37.
PMID: 39696407
PMC: 11658331.
DOI: 10.1186/s40170-024-00366-y.
Jiang R, Ren W, Wang L, Zhang W, Jiang Z, Zhu G
Biomolecules. 2024; 14(10).
PMID: 39456135
PMC: 11505598.
DOI: 10.3390/biom14101202.
Qin R, Fan X, Huang Y, Chen S, Ding R, Yao Y
Transl Oncol. 2024; 50():102156.
PMID: 39405607
PMC: 11736406.
DOI: 10.1016/j.tranon.2024.102156.
Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside.
Fedele P, Santoro A, Pini F, Pellegrino M, Polito G, De Luca M
Biology (Basel). 2024; 13(6).
PMID: 38927289
PMC: 11201027.
DOI: 10.3390/biology13060409.
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways.
Mohanty P, Pande B, Acharya R, Bhaskar L, Verma H
Diseases. 2024; 12(5).
PMID: 38785748
PMC: 11119248.
DOI: 10.3390/diseases12050093.
Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.
Molnar O, Straciuc O, Mihutiu S, Lazar L
Curr Oncol. 2024; 31(5):2508-2526.
PMID: 38785469
PMC: 11119194.
DOI: 10.3390/curroncol31050188.
Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs.
Meynen J, Adriaensens P, Criel M, Louis E, Vanhove K, Thomeer M
Int J Mol Sci. 2024; 25(9).
PMID: 38731909
PMC: 11083579.
DOI: 10.3390/ijms25094690.
FAK and p130Cas modulate stiffness-mediated early transcription and cellular metabolism.
Tumenbayar B, Tutino V, Brazzo 3rd J, Yao P, Bae Y
bioRxiv. 2024; .
PMID: 38293187
PMC: 10827115.
DOI: 10.1101/2024.01.15.575789.
Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer.
Zhang S, Wang Y, Luo D, Cheng Z, Zeng Q, Wang G
J Cell Mol Med. 2023; 28(3):e18059.
PMID: 38140828
PMC: 10844763.
DOI: 10.1111/jcmm.18059.
Cellular dynamics as a marker of normal-to-cancer transition in human cells.
Marques M, de Carvalho A, Martins C, Silva J, Sarter M, Sakai V
Sci Rep. 2023; 13(1):21079.
PMID: 38030663
PMC: 10687084.
DOI: 10.1038/s41598-023-47649-w.
Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019.
Wang M, Liu J, Wang J, Jin Y, Zheng Z
J Diabetes. 2023; 16(3):e13499.
PMID: 38009553
PMC: 10925880.
DOI: 10.1111/1753-0407.13499.
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance.
Cunha A, Silva P, Sarmento B, Queiros O
Pharmaceutics. 2023; 15(11).
PMID: 38004589
PMC: 10675572.
DOI: 10.3390/pharmaceutics15112610.
Lung cancer associated with combustion particles and fine particulate matter (PM) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR).
Holme J, Vondracek J, Machala M, Lagadic-Gossmann D, Vogel C, Le Ferrec E
Biochem Pharmacol. 2023; 216:115801.
PMID: 37696458
PMC: 10543654.
DOI: 10.1016/j.bcp.2023.115801.
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.
Biziotis O, Tsakiridis E, Ali A, Ahmadi E, Wu J, Wang S
Mol Oncol. 2023; 17(11):2235-2256.
PMID: 37584455
PMC: 10620129.
DOI: 10.1002/1878-0261.13508.
Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
Li M, Cao S, Dimou N, Wu L, Li J, Yang J
Chest. 2023; 165(1):213-223.
PMID: 37572975
PMC: 10790176.
DOI: 10.1016/j.chest.2023.08.003.
Prediabetes and the risk of lung cancer incidence and mortality: A meta-analysis.
Shen E, Chen X
J Diabetes Investig. 2023; 14(10):1209-1220.
PMID: 37517054
PMC: 10512911.
DOI: 10.1111/jdi.14057.
Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.
Pourbaghi M, Haghani L, Zhao K, Karimi A, Marinelli B, Erinjeri J
Curr Oncol. 2023; 30(7):6609-6622.
PMID: 37504345
PMC: 10377758.
DOI: 10.3390/curroncol30070485.
The mitochondrial Ca channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation.
Fernandez Garcia E, Paudel U, Noji M, Bowman C, Rustgi A, Pitarresi J
Front Cell Dev Biol. 2023; 11:1082213.
PMID: 37363724
PMC: 10285664.
DOI: 10.3389/fcell.2023.1082213.